Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Bloomer

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1997
Salvage radiotherapy for local failures of lumpectomy and breast irradiationE E Mullen, M Deutsch, W D Bloomer
Lancet (London, England)|September 20, 1975
Doxorubicin, radiotherapy, and oesophageal strictureA Horwich, J J Lokich, W D Bloomer
Cancer Chemotherapy and Pharmacology|September 20, 2001
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in miceM V Papadopoulou, M Ji, W D Bloomer
Oncology Research|August 6, 2003
Synergistic interaction between cyclophosphamide or paclitaxel and the bioreductive compound NLCPQ-1, in vivoM V Papadopoulou, M Ji, W D Bloomer
Japanese Journal of Cancer Research : Gann|August 1, 1992
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agentsM V Papadopoulou, A Mainwaring, W D Bloomer
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivoM V Papadopoulou, M Ji, W D Bloomer
Medical Physics|June 1, 1997
Effective atomic numbers of composite materials for total and partial interaction processes for photons, electrons, and protonsS G Prasad, K Parthasaradhi, W D Bloomer
JAMA|June 28, 1985
Sequelae of breast irradiationR Lipsztein, J F Dalton, W D Bloomer
The British Journal of Cancer. Supplement|July 1, 1996
THNLA-1 as radio/chemosensitiser of EMT-6 tumours in miceM V Papadopoulou, M Ji, W D Bloomer
JAMA|March 12, 1982
Nervous system toxic effects of cancer therapyI D Goldberg, W D Bloomer, D M Dawson
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1997
Salvage radiotherapy for local failures of lumpectomy and breast irradiationE E Mullen, M Deutsch, W D Bloomer
Lancet (London, England)|September 20, 1975
Doxorubicin, radiotherapy, and oesophageal strictureA Horwich, J J Lokich, W D Bloomer
Cancer Chemotherapy and Pharmacology|September 20, 2001
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in miceM V Papadopoulou, M Ji, W D Bloomer
Oncology Research|August 6, 2003
Synergistic interaction between cyclophosphamide or paclitaxel and the bioreductive compound NLCPQ-1, in vivoM V Papadopoulou, M Ji, W D Bloomer
Japanese Journal of Cancer Research : Gann|August 1, 1992
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agentsM V Papadopoulou, A Mainwaring, W D Bloomer
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivoM V Papadopoulou, M Ji, W D Bloomer
Medical Physics|June 1, 1997
Effective atomic numbers of composite materials for total and partial interaction processes for photons, electrons, and protonsS G Prasad, K Parthasaradhi, W D Bloomer
JAMA|June 28, 1985
Sequelae of breast irradiationR Lipsztein, J F Dalton, W D Bloomer
The British Journal of Cancer. Supplement|July 1, 1996
THNLA-1 as radio/chemosensitiser of EMT-6 tumours in miceM V Papadopoulou, M Ji, W D Bloomer
JAMA|March 12, 1982
Nervous system toxic effects of cancer therapyI D Goldberg, W D Bloomer, D M Dawson
Pageof 11